Monash IVF has agreed to a $56 million settlement in a class action involving over 700 former patients whose embryos were mishandled during genetic screenings. Allegations included inaccurate tests leading to the loss of viable pregnancies, and fraudulent activities surrounding clinical trial documentation. This settlement, while confirming the mishap, does not come with any admission of liability from Monash IVF. The firm opted for a resolution through mediation to prioritize patient interests over a lengthy trial process.